Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Glaucoma, Primary Open Angle: early-phase trial registry
3 of 6 indexed Glaucoma, Primary Open Angle trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Glaucoma, Primary Open Angle: 6 US clinical trials tracked, 3 recruiting.
Glaucoma, Primary Open Angle is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Jeffrey L Goldberg, running 1 of these trials.
Enrollment posture brief
Registry condition glaucoma-primary-open-angle
OPEN 3 | RECR 50% | LATE 1 | EARLY 2 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Achalasia (50% recruiting · 8 trials)
Glaucoma, Primary Open Angle lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Glaucoma, Primary Open Angle on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Glaucoma, Primary Open Angle is recruiting above its size-band peers.
3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Glaucoma, Primary Open Angle research.
Jeffrey L Goldberg accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Most Glaucoma, Primary Open Angle trials plan to enrol fewer than 100 people.
Median target enrolment is 77 among the 6 trials that report a genuine target (sentinel values excluded). 6 of those (100%) plan for fewer than 100 participants.
-
Glaucoma, Primary Open Angle research is mostly interventional.
6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Adaptive Optics Retinal Imaging
Food and Drug Administration (FDA)
NCT05370287
Caffeine Consumption in Glaucoma Patients and Healthy Subjects
Wills Eye
NCT03675412
Safety and Feasibility of the ELIOS System in POAG Patients
Elios Vision
NCT05999006
Safety and IOP-Lowering Effects of WB007
Bausch & Lomb Incorporated
NCT04149899
Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert
Wolstan and Goldberg Eye Associates
NCT04465864
NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement
Jeffrey L Goldberg
NCT01408472
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Glaucoma, Primary Open Angle records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Glaucoma, Primary Open Angle trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Glaucoma, Primary Open Angle page
6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Glaucoma, Primary Open Angle trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Jeffrey L Goldberg sponsors the most Glaucoma, Primary Open Angle trials on record, review their full trial history before evaluating a specific study. See Jeffrey L Goldberg's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Glaucoma, Primary Open Angle condition card totals 6 registered trials; most-linked intervention NT-501 CNTF Implant; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.